Matonhodze Baron B, Katsoulis Lynn C, Hofmeyr G Justus
Effective Care Research Unit, University of the Witwatersrand, Parktown, Johannesburg, South Africa.
J Perinat Med. 2002;30(5):405-10. doi: 10.1515/JPM.2002.063.
Oxytocin and various prostaglandin preparations are commonly used for pharmacological induction of labor at term. Some prostaglandin preparations appear to be associated with more fetal meconium passage and maternal gastrointestinal side effects than is oxytocin. These adverse effects may be caused by stimulation of bowel smooth muscle in the mother and in the fetus.
To determine whether the in vitro ileal contractile activities of dinoprostone, misoprostol and oxytocin are in keeping with the variation in rates of meconium staining observed during labor induction with these substances.
The contractile activity of the drugs was tested on isolated rat uterus and ileum mounted in Tyrode's solution.
Uterine contractions were stimulated by all three drugs, whereas ileal contractions were only stimulated by dinoprostone and misoprostol. Oxytocin had no contractile activity on the ileum. Dinoprostone and misoprostol stimulated significantly (p < 0.05) larger uterine contractions than ileal contractions.
These results provide a pharmacological basis for the increased rate of maternal gastrointestinal complaints and meconium passage with labor induction using dinoprostone and misoprostol compared to oxytocin. Based on the above findings, we postulate that the difference in the rates of meconium passage following misoprostol and dinoprostone administration is caused by pharmacokinetic rather than pharmacodynamic differences between the two drugs.
缩宫素和各种前列腺素制剂常用于足月妊娠的药物引产。与缩宫素相比,一些前列腺素制剂似乎与更多的胎儿胎粪排出和母体胃肠道副作用有关。这些不良反应可能是由母亲和胎儿肠道平滑肌的刺激引起的。
确定地诺前列酮、米索前列醇和缩宫素的体外回肠收缩活性是否与使用这些物质引产期间观察到的胎粪染色率变化一致。
在置于台氏液中的离体大鼠子宫和回肠上测试药物的收缩活性。
所有三种药物均刺激子宫收缩,而回肠收缩仅由地诺前列酮和米索前列醇刺激。缩宫素对回肠无收缩活性。地诺前列酮和米索前列醇刺激的子宫收缩明显大于回肠收缩(p<0.05)。
这些结果为与缩宫素相比,使用地诺前列酮和米索前列醇引产时母体胃肠道不适和胎粪排出率增加提供了药理学依据。基于上述发现,我们推测米索前列醇和地诺前列酮给药后胎粪排出率的差异是由两种药物的药代动力学而非药效学差异引起的。